Indigestion Completed Phase Trials for Citrulline (DB00155)

Also known as: Dyspepsia

IndicationStatusPhase
DBCOND0031004 (Indigestion)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01849107Plasma Citrulline: A Marker for Monitoring & Quantifying Radiation-Induced Small Bowel ToxicityDiagnostic